William Cohn - Cardiovascular Systems Director
| CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Director
Dr. William E. Cohn M.D. is Independent Director of the Company. Dr. Cohn was a member of our Board since February 2015. Dr. Cohn is a Vice President of Medical Devices and Director of the Center for Device Innovation at Johnson Johnson. He is also a Cardiothoracic Surgeon and a professor of Surgery at Baylor College of Medicine since 2015.
| Age | 57 |
| Tenure | 9 years |
| Professional Marks | Ph.D |
| Phone | 651 259 1600 |
| Web | https://www.csi360.com |
Cardiovascular Systems Management Efficiency
The company has return on total asset (ROA) of (0.0756) % which means that it has lost $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1518) %, meaning that it created substantial loss on money invested by shareholders. Cardiovascular Systems' management efficiency ratios could be used to measure how well Cardiovascular Systems manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 22.15 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cardiovascular Systems has a current ratio of 5.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Cardiovascular Systems until it has trouble settling it off, either with new capital or with free cash flow. So, Cardiovascular Systems' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cardiovascular Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cardiovascular to invest in growth at high rates of return. When we think about Cardiovascular Systems' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Samuel Riccitelli | Orthopediatrics Corp | 59 | |
| Brenda Furlong | Bruker | 67 | |
| Wilfred Jaeger | Nevro Corp | 62 | |
| Carlton Highsmith | Paragon 28 | 63 | |
| Kevin Unger | Orthopediatrics Corp | 46 | |
| David Hung | Establishment Labs Holdings | 60 | |
| Jonathan Silverstein | Glaukos Corp | 49 | |
| Stephen Fesik | Bruker | 61 | |
| John Freund | Si Bone | 64 | |
| Valery Serdyukov | Si Bone | 72 | |
| Frank Fischer | Nevro Corp | 78 | |
| Marc Kastner | Bruker | 72 | |
| Kevin OBoyle | Nevro Corp | 62 | |
| Peter Soderberg | Integer Holdings Corp | 71 | |
| Peter Robinson | Paragon 28 | 64 | |
| Brian Dempsey | Paragon 28 | 36 | |
| James Hinrichs | Orthofix Medical | 50 | |
| George Philip | Paragon 28 | 67 | |
| Francesco Bianchi | LivaNova PLC | 60 | |
| Andrey Patrushev | Si Bone | 36 | |
| David Bronson | CONMED | 67 | |
Management Performance
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 |
Cardiovascular Systems Leadership Team
Elected by the shareholders, the Cardiovascular Systems' board of directors comprises two types of representatives: Cardiovascular Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardiovascular. The board's role is to monitor Cardiovascular Systems' management team and ensure that shareholders' interests are well served. Cardiovascular Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardiovascular Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edward Brown, Independent Director | ||
| Stephen Rempe, Chief Officer | ||
| Jack Nielsen, Vice President Investor Relations & Corporate Communications | ||
| Peter Hirshman, VP Operations | ||
| Scott Ward, Chairman of the Board, Interim CEO and Presidentident | ||
| BSc MS, Pres Chairman | ||
| Alexander Rosenstein, General Counsel and Corporate Secretary | ||
| Jeffrey MD, Chief Officer | ||
| Laurence Betterley, CFO | ||
| Laura Gillund, Chief Talent Officer | ||
| John Nielsen, VP Communications | ||
| Scott Bartos, Independent Director | ||
| Sandra Sedo, Chief Compliance Officer | ||
| Rhonda Robb, COO | ||
| Jeffrey Points, Chief Officer | ||
| Leslie Trigg, Independent Director | ||
| William Cohn, Director | ||
| Brent Blackey, Independent Director | ||
| Philip Freed, VP Marketing | ||
| Augustine Lawlor, Independent Director | ||
| Paul Koehn, Sr. VP of Quality and Operations | ||
| Robert Thatcher, Chief Healthcare Policy Officer | ||
| Erik Paulsen, Independent Director | ||
| Kevin Kenny, COO | ||
| Martha Aronson, Independent Director |
Cardiovascular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardiovascular Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Shares Owned By Insiders | 3.22 % | |||
| Shares Owned By Institutions | 89.64 % | |||
| Number Of Shares Shorted | 1.74 M | |||
| Price To Earning | 724.24 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cardiovascular Systems in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cardiovascular Systems' short interest history, or implied volatility extrapolated from Cardiovascular Systems options trading.
Pair Trading with Cardiovascular Systems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardiovascular Systems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiovascular Systems will appreciate offsetting losses from the drop in the long position's value.Moving together with Cardiovascular Stock
| 0.71 | BRK-A | Berkshire Hathaway Earnings Call This Week | PairCorr |
Moving against Cardiovascular Stock
| 0.84 | AMKBF | AP Mller | PairCorr |
| 0.83 | GFGY | Granite Falls Energy | PairCorr |
| 0.63 | CSCO | Cisco Systems Earnings Call This Week | PairCorr |
| 0.61 | PRSEF | Prosafe Earnings Call This Week | PairCorr |
| 0.58 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
The ability to find closely correlated positions to Cardiovascular Systems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardiovascular Systems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardiovascular Systems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardiovascular Systems to buy it.
The correlation of Cardiovascular Systems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardiovascular Systems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardiovascular Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardiovascular Systems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |